Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
115,444,746
-
Share change
-
-14,387,307
-
Total reported value
-
$1,753,768,853
-
Put/Call ratio
-
130%
-
Price per share
-
$15.18
-
Number of holders
-
279
-
Value change
-
-$255,755,250
-
Number of buys
-
108
-
Number of sells
-
149
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2020
As of 31 Mar 2020,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
279 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,444,746 shares.
The largest 10 holders included
GLENVIEW CAPITAL MANAGEMENT, LLC, PAULSON & CO. INC., Adelphi Capital LLP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, GMT CAPITAL CORP, LMR Partners LLP, and Mondrian Investment Partners LTD.
This page lists
284
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.